Magazine Article | November 1, 2015

Redefining Clinical Research In The Age Of Genomic Science

Source: Life Science Leader

By Tom Martorelli, historian, nonprofit strategist, and writer

In 2013, TransPoC, Inc. (Translational Proof of Concept) was formed to solve a serious problem: the diminishing number of new drug therapies resulting from oncology research. This problem has become more challenging given the overwhelming volume of genomic data available since the completion of the Human Genome Project in 2003.

Like others, TransPoC’s founders believe the way to accelerate discovering new therapies is through collaboration and data sharing on a large scale. They see it as a classic collective action problem. All “discovery-enabling organizations” know there are inefficiencies and duplication of effort in oncology research. They also see the potential in pooling resources to work from a shared platform.